Inventor · disambiguated record
Robert C. Bast, Jr.
Also filed as: BAST JR ROBERT C · BAST ROBERT · BAST ROBERT C · BAST ROBERT C JR
14 granted patents·18 pending applications·418 citations·filing 1992–2023
93Inventor score
Top patents by PatentIndex Score
32 records- 0196US7494775B2Compositions, kits, and methods for identification, assessment, prevention and therapy of breast and ovarian cancerMILLENNIUM PHARM INC·Filed 2005·Granted Feb 24, 2009·59 cites·9 claims
- 0295US8323906B2Compositions, kits, and methods for identification, assessment, prevention and therapy of breast and ovarian cancerVEIBY OLE PETTER·Filed 2008·Granted Dec 4, 2012·73 cites·14 claims
- 0395US7510842B2Biomarker for ovarian and endometrial cancer: hepcidinVERMILLLION INC·Filed 2006·Granted Mar 31, 2009·108 cites·14 claims
- 0492US7705120B2Compositions, kits, and methods for identification, assessment, prevention, and therapy of breast cancerMILLENNIUM PHARM INC·Filed 2002·Granted Apr 27, 2010·106 cites·24 claims
- 0580US10533227B2Compositions, kits, and methods for identification, assessment, prevention and therapy of breast and ovarian cancerMILLENNIUM PHARM INC·Filed 2015·Granted Jan 14, 2020·2 cites·24 claims
- 0673US2024082232A1Compositions and methods for treatment of ovarian and breast cancerUNIV TEXAS·Filed 2023·Application pending·0 cites
- 0771US7601505B2Compositions, kits, and methods for identification, assessment, prevention, and therapy of breast cancerMILLENNIUM PHARM INC·Filed 2004·Granted Oct 13, 2009·10 cites·24 claims
- 0871US2010105051A1Compositions, kits, and methods for identification, assessment, prevention, and therapy of breast cancerMILLENNIUM PHARM INC·Filed 2009·Application pending·0 cites
- 0968US7871775B2Compositions and methods for the identification, assessment, prevention and therapy of human cancersMILLENNIUM PHARM INC·Filed 2007·Granted Jan 18, 2011·0 cites·4 claims
- 1066US8221984B2Biomarkers for ovarian cancerFUNG ERIC T·Filed 2008·Granted Jul 17, 2012·3 cites·9 claims
- 1166US2022296583A1Compositions and methods for treatment of ovarian and breast cancerUNIV TEXAS·Filed 2022·Application pending·0 cites
- 1265US2008311573A1Compositions, kits, and methods for identification, assessment, prevention, and therapy of breast cancerMILLENNIUM PHARM INC·Filed 2007·Application pending·0 cites
- 1364US5486456AMethod of diagnosing ovarian, endometrial, and colon cancers with monoclonal antibodies OXA and OXBUNIV DUKE·Filed 1994·Granted Jan 23, 1996·26 cites·19 claims
- 1463US7504222B2Compositions, kits, and methods for identification, assessment, prevention, and therapy of breast cancerMILLENNIUM PHARM INC·Filed 2002·Granted Mar 17, 2009·6 cites·15 claims
- 1560US5366866AMethod of diagnosing ovarian and endometrial cancer with monoclonal antibodies OXA and OXBUNIV DUKE·Filed 1992·Granted Nov 22, 1994·25 cites·21 claims
- 1658US2013102482A1Compositions, kits, and methods for identification, assessment, prevention and therapy of breast and ovarian cancerMILLENNIUM PHARM INC·Filed 2012·Application pending·0 cites
- 1758US2011092388A1Compositions, kits, and methods for identification, assessment, prevention, and therapy of breast cancerMILLENNIUM PHARM INC·Filed 2010·Application pending·0 cites
- 1855US2010068724A1Biomaker for ovarian and endometrial cancer: hepcidinVERMILLLION INC·Filed 2009·Application pending·0 cites
- 1955US2012141604A1Novel compositions and methods for the identification, assessment, prevention and therapy of human cancersCLARK EDWIN·Filed 2011·Application pending·0 cites
- 2055US2010075325A1Compositions, kits, and methods for identification, assessment, prevention, and therapy of breast cancerMILLENNIUM PHARM INC·Filed 2009·Application pending·0 cites
- 2154US2023270891A1Methods and Apparatuses for the Synthesis of Drug-Loaded Magnetic Micelle AggregatesIMAGION BIOSYSTEMS INC·Filed 2023·Application pending·0 cites
- 2254US2003087250A1Nucleic acid molecules and proteins for the identification, assessment, prevention, and therapy of ovarian cancerMILLENNIUM PHARM INC·Filed 2002·Application pending·0 cites
- 2354US2005214831A1Nucleic acid molecules and proteins for the identification, assessment, prevention, and therapy of ovarian cancerMILLENNIUM PHARM INC·Filed 2005·Application pending·0 cites
- 2453US2009136961A1Novel compositions and methods for identification, assessment, prevention, and therapy of ovarian cancerMILLENNIUM PHARM INC·Filed 2008·Application pending·0 cites
- 2553US2010009358A1Compositions, kits, and methods for identification, assessment, prevention, and therapy of breast cancerMILLENNIUM PHARM INC·Filed 2008·Application pending·0 cites
- 2651US2014038837A1Biomarkers for the detection of early stage ovarian cancerUNIV TEXAS·Filed 2013·Application pending·0 cites
- 2750US2010291068A1Nucleic acid molecules and proteins for the identification, assessment, prevention, and therapy of ovarian cancerMILLENNIUM PHARM INC·Filed 2010·Application pending·0 cites
- 2850US2007190550A1Novel compositions and methods for the identification, assessment, prevention, and therapy of human cancersUNIV TEXAS·Filed 2006·Application pending·0 cites
- 2946US8080368B2Compositions and methods for the identification, assessment, prevention and therapy of human cancersCLARK EDWIN·Filed 2010·Granted Dec 20, 2011·0 cites·10 claims
- 3045US7470509B2Compositions and methods for the identification, assessment, prevention and therapy of ovarian cancerMILLENNIUM PHARM INC·Filed 2003·Granted Dec 30, 2008·0 cites·19 claims
- 3144US2010304993A1Biomarkers for the detection of early stage ovarian cancerVERMILLLION INC·Filed 2010·Application pending·0 cites
- 3221US7183401B1NOEY2 gene compositions and methods of useUNIV TEXAS·Filed 1998·Granted Feb 27, 2007·0 cites·23 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →